Please login to the form below

Not currently logged in
Email:
Password:

Amryt Pharma appoints Jordi Casals as head of Europe

He joins the company from Aegerion Pharmaceuticals

Jordi CasalsAmryt Pharma, a company focused on treatments for rare and orphan diseases, has appointed Jordi Casals as the biopharma’s head of Europe.

Taking responsibility for leading and developing Amryt’s European operations, Casals’ new role will see him initially focus on the sales growth of the company’s commercial asset Lojuxta - a treatment for adult patients with Homozygous Familial Hypercholesterolaemia.

Dr Joe Wiley, chief executive officer of Amryt, said: “I am pleased to welcome Jordi to our senior management team as the company’s head of Europe.

“His significant commercial experience of European markets will help us to drive and further develop Amryt’s growth across this key region.”

Casal has over 20 years’ experience in the pharmaceutical and biotech industry and most recently worked for Aegerion Pharmaceuticals as a consultant, managing its commercial operations in the Iberia region.

Prior to this, he worked for eight years at Alexion Pharmaceuticals, latterly as vice president commercial operations, Western Europe.

9th March 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics